GILD 50.50 -0.13 / Gilead Sciences, Inc. GILD 50.50 -0.13 / Gilead Sciences, Inc. Price Target | Benzinga

Thursday, March 15, 2012

UPDATE: Stifel Nicolaus Resumes Buy, $57 PT on Gilead Sciences (Analyst Color, GILD, Price Target, Initiation, Intraday Update, Analyst Ratings / Thu, 11:43am)

Monday, February 27, 2012

Deutsche Bank Reiterates Buy, $57 PT on Gilead Sciences (Analyst Color, GILD, Price Target, Reiteration, Intraday Update, Analyst Ratings / Mon, 10:48am)

Friday, February 24, 2012

UPDATE: Deutsche Bank Cuts Target to $57 on Gilead Sciences (Analyst Color, GILD, Price Target, Reiteration, Intraday Update, Analyst Ratings / Fri, 11:29am)

Friday, February 10, 2012

Morgan Stanley Initiates Coverage on Gilead Sciences at Overweight, Announces PT of $65 (GILD, Price Target, Initiation, Analyst Ratings / Fri, 07:41am)

Friday, February 03, 2012

Gilead Sciences Soars On "Striking" Clinical Trial Data (Analyst Color, Earnings, GILD, JPM, Long Ideas, News, Guidance, Short Ideas, Price Target, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Fri, 02:33pm)
UPDATE: JP Morgan Raises Target to $65 on Gilead Sciences (Analyst Color, GILD, Price Target, Reiteration, Intraday Update, Analyst Ratings / Fri, 10:36am)
UPDATE: Deutsche Bank Raises Target to $66 on Gilead Sciences (Analyst Color, GILD, Price Target, Reiteration, Pre-Market Outlook, Analyst Ratings / Fri, 08:13am)
JP Morgan Raises PT on Gilead Sciences to $65 (GILD, Price Target, Pre-Market Outlook, Analyst Ratings / Fri, 07:59am)

Thursday, January 26, 2012

Brean Murray Carret & Co. Raises Gilead Sciences PT To $60 (Analyst Color, GILD, Price Target, Analyst Ratings / Thu, 05:00pm)

Tuesday, January 10, 2012

Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? (ABT, ACHN, BMY, GILD, IDIX, INHX, JNJ, Long Ideas, MRK, News, NVS, PFE, VRTX, VRUS, Short Ideas, Price Target, Rumors, M&A, Events, Intraday Update, Analyst Ratings, Movers, Trading Ideas / Tue, 03:54pm)

Monday, December 05, 2011

Citi Reiterates Buy, $49 PT on Gilead (Analyst Color, GILD, News, VRUS, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Mon, 01:11pm)

Tuesday, November 29, 2011

Brean Murray Raises Inhibitex PT to $19 From $12 (Analyst Color, GILD, INHX, Long Ideas, News, VRUS, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 01:25pm)

Monday, November 28, 2011

Deutsche Bank Has Buy, $53 PT On Gilead (Analyst Color, GILD, News, VRUS, Price Target, Reiteration, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Mon, 12:37pm)

Tuesday, November 22, 2011

Brean Murray Downgrades Pharmasset to "Hold" (Analyst Color, GILD, News, VRUS, Downgrades, Price Target, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Tue, 12:29pm)
UPDATE: Bank of America Upgrades Gilead Sciences to Buy (Analyst Color, GILD, News, Upgrades, Price Target, M&A, Analyst Ratings / Tue, 10:52am)
Bank of America Upgrades Gilead Sciences to Buy, PO Raised to $55 (GILD, Upgrades, Price Target, Analyst Ratings / Tue, 10:44am)
UDPATE: JP Morgan Maintains Overweight, Raises PT to $55 on Gilead Sciences (Analyst Color, GILD, News, Price Target, M&A, Pre-Market Outlook, Analyst Ratings / Tue, 10:18am)
UBS Downgrades Pharmasset to Neutral (GILD, VRUS, Downgrades, Price Target, Pre-Market Outlook, Analyst Ratings / Tue, 08:19am)
BMO Capital Markets Upgrades Gilead Sciences to Outperform (GILD, Upgrades, Price Target, Pre-Market Outlook, Analyst Ratings / Tue, 08:10am)
JP Morgan Raises PT on Gilead Sciences to $55 (GILD, Price Target, Pre-Market Outlook, Analyst Ratings / Tue, 07:53am)

Monday, November 21, 2011

UPDATE: Piper Jaffray Downgrades Pharmasset to Neutral, PT Raised to $137 (Analyst Color, GILD, News, VRUS, Downgrades, Price Target, M&A, Analyst Ratings / Mon, 12:10pm)

Friday, September 16, 2011

Financial Breakfast: Morning News Summary for September 16, 2011 (AWH, Earnings, GILD, Long Ideas, News, RIMM, TRH, VECO, Futures, Guidance, Short Ideas, Upgrades, Commodities, Downgrades, Price Target, Forex, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas / Fri, 07:44am)
Goldman Sachs Upgrades Gilead Sciences To Buy, $46 PT (GILD, Upgrades, Price Target, Analyst Ratings / Fri, 05:55am)

Tuesday, August 16, 2011

J.P. Morgan Adding Gilead Sciences To Focus List (Analyst Color, GILD, Price Target, Analyst Ratings / Tue, 08:17am)

Wednesday, July 27, 2011

UPDATE: JP Morgan Raises PT on Gilead Sciences from $45 to $50 (Analyst Color, GILD, Price Target, Analyst Ratings / Wed, 09:53am)
Oppenheimer Price Target and Rating Updates 7/27/11 (AMZN, GILD, JNPR, NFLX, PVTB, QCOR, Downgrades, Price Target, Reiteration, Analyst Ratings / Wed, 08:41am)
UPDATE: Oppenheimer Raises PT on Gilead Sciences to $46 (Analyst Color, GILD, Price Target, Analyst Ratings / Wed, 07:26am)
JP Morgan Raises PT on Gilead Sciences To $50 (GILD, Price Target, Analyst Ratings / Wed, 07:14am)
Oppenheimer Raises PT On Gilead Sciences To $46 (GILD, Price Target, Analyst Ratings / Wed, 06:12am)

Monday, July 18, 2011

J.P. Morgan Overweight On Gilead Sciences (Analyst Color, GILD, Price Target, Analyst Ratings / Mon, 11:59am)

Tuesday, July 12, 2011

Oppenheimer Discusses Phase III Results From Gilead (Analyst Color, GILD, Price Target, Analyst Ratings / Tue, 09:20am)

Wednesday, June 29, 2011

UPDATE: Piper Jaffray Upgrades Gilead Sciences to Overweight (Analyst Color, GILD, Upgrades, Price Target, Analyst Ratings / Wed, 07:31am)
Piper Jaffray Upgrades Gilead Sciences To Overweight, Raises PT To $53 (GILD, Upgrades, Price Target, Analyst Ratings / Wed, 06:28am)

Friday, June 03, 2011

J.P. Morgan Overweight On Gilead Sciences After Meeting With Management (Analyst Color, GILD, Price Target, Analyst Ratings / Fri, 07:26am)

Thursday, April 21, 2011

UPDATE: Citi Raising Price Target On Gilead Sciences Inc (GILD) (Analyst Color, GILD, Price Target, Analyst Ratings / Thu, 10:05am)
Citigroup Raises PT On Gilead Sciences To $44 (GILD, Price Target, Analyst Ratings / Thu, 07:40am)